Right To Try Individualized Treatments.

This bill allows patients with life-threatening or severely debilitating illnesses to access custom-made investigational drugs, biological products, or devices that have not yet been approved by the federal government. To qualify, a patient must consult with a doctor, confirm that standard treatments are unlikely to help, and provide written informed consent acknowledging the risks and potential costs. The legislation permits manufacturers to offer these treatments for free or at a cost to the patient, while also protecting doctors from disciplinary action for recommending them and shielding the patient's heirs from debt if the patient passes away during treatment. Additionally, the bill clarifies that using these treatments may affect eligibility for hospice care and that health insurance plans are not required to cover the expenses.